EUROPEAN MARKETS FOR CRITICAL CARE BLOOD GAS MONITORING PRODUCTS

117 Pages | 35 Exhibits | 2009 Analysis | Forecasts Through 2013

OVERVIEW:
Blood gas measurements are a valuable tool used by clinicians to monitor patients with respiratory distress symptoms as well as those undergoing prolonged anesthesia. Each year in Europe, nearly 240 million arterial blood gas tests are performed; of these, approximately half are performed on patients in critically ill or unstable conditions.

In 2008, sales of blood gas monitoring products in the European countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.) totaled approximately $660.1 million; over the forecast period covered by this report, sales of these products are expected to increase at a compound annual rate of 3.3%, reaching an estimated $778.3 million in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of blood gas monitoring. Market segments covered in this report include arterial blood gas sampling products, capnography/end-tidal carbon dioxide monitors, laboratory-based blood gas analyzers, point of care blood gas analyzers, and pulse oximeters. This report also provides an analysis of critical care in Europe as well as an overview of the healthcare markets of France, Germany, Italy, Spain, and the U.K.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Critical Care Overview
ii. European Markets for Blood Gas Monitoring Products
	a. Market Analysis
iii. Methodology

Exhibit ES-1: Europe, Blood Gas Monitoring Products, Market Forecast, 2008-2013

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union
	1.1.1 A Common Currency
	1.1.2 Regulatory Policies
	1.1.3 Reimbursement
	1.1.4 Healthcare Spending
1.2 Selected European National Healthcare Profiles
	1.2.1 France
		1.2.1.1 Healthcare Organization and Reform
		1.2.1.2 Hospital Services
		1.2.1.3 Medical Device Reimbursement
	1.2.2 Germany
		1.2.2.1 Healthcare Organization and Reform
		1.2.2.2 Hospital Services
		1.2.2.3 Medical Device Reimbursement
	1.2.3 Italy
		1.2.3.1 Healthcare Organization and Reform
		1.2.3.2 Hospital Services
		1.2.3.3 Medical Device Reimbursement
	1.2.4 Spain
		1.2.4.1 Healthcare Organization and Reform
		1.2.4.2 Hospital Services
		1.2.4.3 Medical Device Reimbursement
	1.2.5 United Kingdom
		1.2.5.1 Healthcare Organization and Reform
		1.2.5.2 Hospital Services
		1.2.5.3 Medical Device Reimbursement

Exhibit 1-1: European Union, Medical Devices Risk Classification System
Exhibit 1-2: Europe, Population Statistics Comparison for the Years 2008 and 2018
Exhibit 1-3: France, Selected National Healthcare Statistics
Exhibit 1-4: Germany, Selected National Healthcare Statistics
Exhibit 1-5: Italy, Selected National Healthcare Statistics
Exhibit 1-6: Spain, Selected National Healthcare Statistics
Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics

2. OVERVIEW OF THE CRITICAL CARE ENVIRONMENT

2.1 Conditions Treated in the Critical Care Unit
2.2 Critical Care Unit Staffing
	2.2.1 Intensivists
	2.2.2 Nurses and Other Allied Healthcare Professionals
2.3 Critical Care Units, by Size and Type
2.4 Equipment and Products Used in the Critical Care Setting
	2.4.1 Invasive and Noninvasive Equipment and Products
	2.4.2 Transport Equipment and Products
2.5 Critical Access Hospital Designation
2.6 Issues Affecting Critical Care Delivery
	2.6.1 Patient Demographics
	2.6.2 Managed Care
	2.6.3 Healthcare Personnel Shortages
	2.6.4 Trends in Critical Care Product Purchasing

Exhibit 2-1: 2006, Number of Anesthetists/Intensivists in Selected European Countries 
Exhibit 2-2: Selected Critical Care Nursing and Allied Healthcare Responsibilities
Exhibit 2-3: 2006, Number of Emergency Rooms and Beds in Selected European Countries
Exhibit 2-4: 2006, Total Equipped Positions, by Type of Intensive Care Unit and Facility in Selected European Countries
Exhibit 2-5: 2006, France, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-6: 2006, Germany, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-7: 2006, Italy, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-8: 2006, Spain, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-9: 2006, United Kingdom, Total Equipped Positions, by Type of Intensive Care Unit and Facility

3. EUROPEAN MARKETS FOR CRITICAL CARE BLOOD GAS MONITORING PRODUCTS

3.1 Overview of Blood Gases
	3.1.1 Arterial Blood Gas Sampling
	3.1.2 Arterial Blood Gas Monitoring Methods
3.2 Point of Care Blood Gas Analyzers
	3.2.1 Market Forecast
	3.2.2 Competitive Analysis
3.3 Laboratory-Based Blood Gas Analyzers
	3.3.1 Market Forecast
	3.3.2 Competitive Analysis
3.4 Arterial Blood Gas Sampling Devices
	3.4.1 Market Forecast
	3.4.2 Competitive Analysis
3.5 Pulse Oximeters
	3.5.1 Market Forecast
	3.5.2 Competitive Analysis
3.6 Capnography/End-Tidal Carbon Dioxide Monitoring
	3.6.1 Market Forecast
	3.6.2 Competitive Analysis
3.7 Combined Market Forecast, Blood Gas Monitoring Systems

Exhibit 3-1: 2009, Selected Point of Care Blood Gas Testing Products
Exhibit 3-2: Europe, Point of Care Blood Gas Testing Products, Market Forecast, 2008-2013
Exhibit 3-3: 2008, Europe, Point of Care Blood Gas Testing Products Market, Share by Supplier
Exhibit 3-4: 2009, Selected Laboratory-Based Blood Gas Analyzers
Exhibit 3-5: Europe, Laboratory-Based Blood Gas Analyzers, Market Forecast, 2008-2013
Exhibit 3-6: 2008, Europe, Laboratory-Based Blood Gas Analyzers Market, Share by Supplier
Exhibit 3-7: 2009, Selected Arterial Blood Gas Sampling Devices
Exhibit 3-8: Europe, Arterial Blood Gas Sampling Devices, Market Forecast, 2008-2013
Exhibit 3-9: 2008, Europe, Arterial Blood Gas Sampling Devices Market, Share by Supplier
Exhibit 3-10: 2009, Selected Pulse Oximetry Products
Exhibit 3-11: Europe, Pulse Oximetry Products, Market Forecast, 2008-2013
Exhibit 3-12: 2008, Europe, Pulse Oximetry Monitors Market, Share by Supplier
Exhibit 3-13: Advantages and Disadvantages of Mainstream and Sidestream Capnography Sampling
Exhibit 3-14: 2009, Selected Capnography-Only Units
Exhibit 3-15: 2009, Selected Capnography/Oximetry Units
Exhibit 3-16: Europe, Capnography/End-Tidal Carbon Dioxide Monitoring Products, Market Forecast, 2008-2013
Exhibit 3-17: 2008, Europe, Capnography/End-Tidal Carbon Dioxide Monitors Market, Share by Supplier
Exhibit 3-18: Europe, Blood Gas Monitoring Products, Combined Market Forecast, 2008 to 2013

4. COMPANY PROFILES

4.1 Abbott Laboratories
4.2 Covidien LTD
4.3 Danaher Corporation
4.4 General Electric Company
4.5 Masimo Corporation
4.6 Roche Holding AG
4.7 Royal Philips Electronics NV
4.8 Siemens AG
4.9 Smiths Group PLC
4.10 Werfen Group S.A.

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Covidien LTD
  3. Danaher Corporation
  4. General Electric Company
  5. Masimo Corporation
  6. Roche Holding AG
  7. Royal Philips Electronics NV
  8. Siemens AG
  9. Smiths Group PLC
  10. Werfen Group S.A.
Contact Us

Need help finding medtech research? Let us help you!